Skip to main content

Table 2 Presence of risk factors in cases versus controlsa

From: Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study

Risk factor (days of ICU stay)

All (n = 352) n(%)

Cases (n = 88) n(%)

Controls (n = 264)

n(%)

P value

OR (95% CI)

Broad-spectrum antibiotics (-7 to 0)

80 (22.7)

30 (34.1)

50 (18.9)

0.005

2.21 (1.29 to 3.79)

Broad-spectrum antibiotics (1 to 3)

296 (84.1)

85 (96.6)

211 (79.9)

< 0.001

7.12 (2.17 to 23.4)

Broad-spectrum antibiotics (-7 to 3)

298 (84.7)

85 (96.6)

213 (80.7)

< 0.001

6.74 (2.06 to 22.33)

Central venous catheter (1 to 3)

272 (77.3)

81 (92)

191 (72.3)

< 0.001

4.42 (1.95 to 10.02)

Surgery (-7 to 0)

40 (11.4)

11 (12.5)

29 (11)

0.700

1.16 (0.55 to 2.43)

Surgery (-7 to 3)

224 (63.6)

62 (70.5)

162 (61.4)

0.159

1.50 (0.89 to 2.53)

Abdominal surgery (-7 to 3)

92 (26.1)

40 (45.5)

52 (19.7)

< 0.001

3.40 (2.02 to 5.70)

Immunosuppressants (-7 to 0)

38 (10.8)

15 (17)

23 (8.7)

0.045

2.15 (1.07 to 4.34)

Pancreatitis (-7 to 3)

6 (1.7)

2 (2.3)

4 (1.5)

0.642

1.51 (0.27 to 8.40)

TPN (1 to 3)

69 (19.6)

33 (37.5)

36 (13.6)

< 0.001

3.80 (2.18 to 6.63)

Dialysis (1 to 3)

32 (9.1)

10 (11.4)

22 (8.3)

0.396

1.41 (0.64 to 3.11)

Systemic corticosteroids (-7 to 3)

134 (38.1)

41 (46.6)

93 (35.2)

0.076

1.60 (0.98 to 2.62)

Diabetes

101 (28.7)

26 (29.5)

75 (28.4)

0.892

1.06 (0.62 to 1.80)

Mechanical ventilation (-7 to 3)

210 (59.7)

56 (63.6)

154 (58.3)

0.413

1.23 (0.75 to 2.03)

Mean APACHE II score, day 1 (± SD)

15.9 (9.5)

17.0 (8.8)

15.5 (9.7)

0.195

1.03 (0.99 to 1.06)

Mean pre-ICU LOS, days (± SD)

1.7 (0.24)

3 (7.3)

1.3 (3.0)

0.036

1.08 (1.01 to 1.14)

  1. OR, odds ratio; CI, confidence interval; TPN, total parenteral nutrition; APACHE, Acute Physiology and Chronic Health Evaluation; LOS, length of stay.